Inhibition of cytokine production by a new inotropic agent, vesnarinone, in human lymphocytes, T cell line, and monocytic cell line
- 31 December 1994
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 54 (1) , PL11-PL16
- https://doi.org/10.1016/0024-3205(94)00580-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effects of Vesnarinone on Morbidity and Mortality in Patients with Heart FailureNew England Journal of Medicine, 1993
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992
- Role of Interleukin‐l in Infectious DiseasesImmunological Reviews, 1992
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991
- Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart FailureNew England Journal of Medicine, 1990
- CYTOKINES: COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSESAnnual Review of Biochemistry, 1990
- A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failureCardiovascular Drugs and Therapy, 1990
- New Positive Inotropic Agent OPC-8212 Modulates Single Ca2+ Channels in Ventricular Myocytes of Guinea PigJournal of Cardiovascular Pharmacology, 1989
- Beneficial effect of OPC-8212 (3,4-dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2(1H)-quinolinone) on myocardial oxygen consumption in dogs with ischemic heart failure.Japanese Circulation Journal, 1986